The event, held at Cipriani 25 Broadway, celebrated NMDP’s mission and the impact on 7,994 lives through cell therapy in 2024 for patients battling blood cancers and blood disorders—the most ever ...

Maxim Group LLC acted as sole book-running manager for the offering.

Agomab Therapeutics NV (“Agomab”) today announced late-breaking interim data from the ongoing STENOVA 1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal (GI)-restricted small molecule ...

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced that the United States Court of Appeals for the Federal ...

Iantrek, Inc., a leader in bio-interventional ophthalmic surgery (BIOS), today announced it has surpassed 2,000 AlloFlo™ Uveo ...

The "Miracle in the Making" program is a testament to Faithful Fertility Collective's dedication to fostering hope and ...

In an industry filled with exaggerated claims and underwhelming results, Alpha Bites Gummies stands out for its transparency ...

Great Speech’s evidence-based virtual therapy model has supported patients with a wide range of communication challenges—from articulation and fluency to cognitive and social communication disorders.

H.H.C. Group IMRs offer several benefits, including protecting patients, improving internal review processes, and potentially reducing litigation. They also play a crucial role in ensuring compliance ...

After the transaction Saga Pure ASA and Ferncliff Listed Dai AS has no holding of shares in Vistin Pharma ASA. Øystein Stray Spetalen and associated parties have a holding of 331,886 shares in Vistin ...

Company to Host Conference Call, May 13, 2025 at 4:30 p.m. ET ...

The Ferrari Foundation is proud to announce the opening of applications for the 2025 Adam Ferrari Health Science Scholarship. Founded by Phoenix Energy CEO Adam Ferrari and his immediate family, the ...